Gecse, Krisztina B.
Lakatos, Péter L.
Article History
First Online: 11 January 2017
Competing interests
: K.B.G. has received consultancy fees from AbbVie, Amgen, Ferring, Hospira, MSD, Pfizer, Sandoz, Takeda and Tigenix. P.L.L. has received consultancy fees from AbbVie, Celgene, Celltrion, Ferring, Hospira, Mitsubichi Tanabe Pharma, MSD, Pfizer, Roche and Takeda.